Mineralocorticoid Receptor-Associated Hypertension and Its Organ Damage: Clinical Relevance for Resistant Hypertension

Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension

(2013) James R. Sowers   ANNALS OF INTERNAL MEDICINE

Management of Blood Pressure in Patients With Diabetes

(2011) E. Grossman et al.   AMERICAN JOURNAL OF HYPERTENSION

Cross Talk Between O-GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription, and Chronic Disease

(2011) Gerald W. Hart et al.   Annual Review of Biochemistry

Mineralocorticoid Receptor Blockade in Chronic Kidney Disease

(2011) Matthew J. Volk et al.   CURRENT HYPERTENSION REPORTS

The Role of Aldosterone in the Metabolic Syndrome

(2011) Marie Briet et al.   CURRENT HYPERTENSION REPORTS

Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009-

(2011) Tetsuo Nishikawa et al.   ENDOCRINE JOURNAL

Coactivation of SF-1-Mediated Transcription of Steroidogenic Enzymes by Ubc9 and PIAS1

(2011) Noriko Suda et al.   ENDOCRINOLOGY

Cell Membrane–Associated Mineralocorticoid Receptors?

(2011) Alexander W. Krug et al.   HYPERTENSION

GPR30, Mineralocorticoid Receptors, and the Rapid Vascular Effects of Aldosterone

(2011) John W. Funder   HYPERTENSION

GPR30 Expression Is Required for the Mineralocorticoid Receptor–Independent Rapid Vascular Effects of Aldosterone

(2011) Robert Gros et al.   HYPERTENSION

Prevalence of Resistant Hypertension in the United States, 2003–2008

(2011) Stephen D. Persell   HYPERTENSION

Obstructive Sleep Apnea

(2011) Rodrigo P. Pedrosa et al.   HYPERTENSION

Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor–dependent pathway

(2011) Shigeru Shibata et al.   JOURNAL OF CLINICAL INVESTIGATION

Positive relationship of sleep apnea to hyperaldosteronism in an ethnically diverse population

(2011) John J. Sim et al.   JOURNAL OF HYPERTENSION

Are melatonin and its receptor agonist specific antihypertensive modulators of resistant hypertension caused by disrupted circadian rhythm?

(2011) Kazuomi Kario   Journal of the American Society of Hypertension

Mineralocorticoid receptor activation and blockade: an emerging paradigm in chronic kidney disease

(2011) Jean-Philippe Bertocchio et al.   KIDNEY INTERNATIONAL

Obesity-Related Hypertension: Epidemiology, Pathophysiology, and Clinical Management

(2010) Theodore A. Kotchen   AMERICAN JOURNAL OF HYPERTENSION

Cardiovascular and Renal Damage in Primary Aldosteronism: Outcomes After Treatment

(2010) L. A. Sechi et al.   AMERICAN JOURNAL OF HYPERTENSION

Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications

(2010) Pedro Geraldes et al.   CIRCULATION RESEARCH

Aldosterone: Role in Edematous Disorders, Hypertension, Chronic Renal Failure, and Metabolic Syndrome

(2010) R. W. Schrier et al.   Clinical Journal of the American Society of Nephrology

Resistant Hypertension and Sleep Apnea: Pathophysiologic Insights and Strategic Management

(2010) Stephen K. Williams et al.   Current Diabetes Reports

Aldosterone in the Pathogenesis of Chronic Kidney Disease and Proteinuria

(2010) Yee Lu et al.   CURRENT HYPERTENSION REPORTS

Mineralocorticoid Receptor Antagonists and the Metabolic Syndrome

(2010) Amir Tirosh et al.   CURRENT HYPERTENSION REPORTS

Aldosterone blockade in chronic kidney disease: can it improve outcome?

(2010) Robert D Toto   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

O-GlcNAc modification, insulin signaling and diabetic complications

(2010) T. Issad et al.   DIABETES & METABOLISM

Position Paper: Rapid responses to steroids: current status and future prospects

(2010) Alexandra Wendler et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

The L-, N-, and T-type triple calcium channel blocker benidipine acts as an antagonist of mineralocorticoid receptor, a member of nuclear receptor family

(2010) Hiromichi Kosaka et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Elevated Mineralocorticoid Receptor Activity in Aged Rat Vascular Smooth Muscle Cells Promotes a Proinflammatory Phenotype via Extracellular Signal-Regulated Kinase 1/2 Mitogen-Activated Protein Kinase and Epidermal Growth Factor Receptor-Dependent Pathways

(2010) Alexander W. Krug et al.   HYPERTENSION

NF-YC Functions as a Corepressor of Agonist-bound Mineralocorticoid Receptor

(2010) Ayano Murai-Takeda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Adipokines and Cardiometabolic Profile in Primary Hyperaldosteronism

(2010) Gianluca Iacobellis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism

(2010) Z Šomlóová et al.   JOURNAL OF HUMAN HYPERTENSION

Cyclin-Dependent Kinase 5 Modulates the Transcriptional Activity of the Mineralocorticoid Receptor and Regulates Expression of Brain-Derived Neurotrophic Factor

(2010) Tomoshige Kino et al.   MOLECULAR ENDOCRINOLOGY

Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms

(2010) Faiez Zannad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dual Blockade of the Renin-Angiotensin-Aldosterone System: Beyond the ACE Inhibitor and Angiotensin-II Receptor Blocker Combination

(2009) A. S. Bomback et al.   AMERICAN JOURNAL OF HYPERTENSION

Targeting the protein kinase C family in the diabetic kidney: lessons from analysis of mutant mice

(2009) M. Meier et al.   DIABETOLOGIA

Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report

(2009) K Gaddam et al.   JOURNAL OF HUMAN HYPERTENSION

Inhibitory effects of a dihydropyridine calcium channel blocker on renal injury in aldosterone-infused rats

(2009) Yu-Yan Fan et al.   JOURNAL OF HYPERTENSION

Aldosterone-receptor antagonism in hypertension

(2009) Pieter M Jansen et al.   JOURNAL OF HYPERTENSION

The mineralocorticoid receptor and its coregulators

(2009) Jun Yang et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

(2009) U. F. Mehdi et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

EGF Receptor as a Drug Target in Arterial Hypertension

(2009) J. Beltowski et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

New aspects of rapid aldosterone signaling

(2009) C. Grossmann et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Osmotic Stress Regulates Mineralocorticoid Receptor Expression in a Novel Aldosterone-Sensitive Cortical Collecting Duct Cell Line

(2009) Say Viengchareun et al.   MOLECULAR ENDOCRINOLOGY

Salt-sensitive hypertension in circadian clock–deficient Cry-null mice involves dysregulated adrenal Hsd3b6

(2009) Masao Doi et al.   NATURE MEDICINE

Change in Proteinuria After Adding Aldosterone Blockers to ACE Inhibitors or Angiotensin Receptor Blockers in CKD: A Systematic Review

(2008) Andrew S. Bomback et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Cardiovascular Outcomes in Patients With Primary Aldosteronism After Treatment

(2008) Cristiana Catena   ARCHIVES OF INTERNAL MEDICINE

The Role of Mineralocorticoid Receptor Expression in Brain Remodeling after Cerebral Ischemia

(2008) Naofumi Oyamada et al.   ENDOCRINOLOGY

A Number of Marketed Dihydropyridine Calcium Channel Blockers Have Mineralocorticoid Receptor Antagonist Activity

(2008) Jessica D. Dietz et al.   HYPERTENSION

Aldosterone and Metabolic Syndrome

(2008) Alexander W. Krug et al.   HYPERTENSION

Resistant Hypertension: Diagnosis, Evaluation, and Treatment

(2008) David A. Calhoun et al.   HYPERTENSION

Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline

(2008) John W. Funder et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease

(2008) Shigeru Shibata et al.   NATURE MEDICINE